​
​

Adamis Pharmaceuticals Ownership | Who Owns Adamis Pharmaceuticals?

OverviewChart

Adamis Pharmaceuticals Ownership Summary

Adamis Pharmaceuticals is owned by 18.04% institutional investors, and 81.96% retail investors. Fidelity® Extended Market Index is the top mutual fund, with 1.96% of its assets in Adamis Pharmaceuticals shares.

ADMP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAdamis Pharmaceuticals18.04%-81.96%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustrySpecialty & Generic Drug Manufacturers Stocks33.38%9.20%57.42%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202347-2.08%27,578,759116.45%1825.98%14-26.32%7-30.00%
Dec 31, 20224814.29%12,741,373-0.87%811.79%19171.43%10-
Sep 30, 202242-10.64%12,853,658-0.05%811.88%7-46.15%1025.00%
Jun 30, 202247-4.08%12,860,150-0.47%811.78%1330.00%8-42.86%
Mar 31, 202249-15.52%12,920,867-8.87%82.53%10-52.38%1475.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity® Extended Market Index197.42K1.96%-
Vanguard Institutional Extnd Mkt Idx Tr33.99K0.34%3.90K
Fidelity® Total Market Index2.86K0.03%-
Fidelity® Series Total Market Index2.39K0.02%-
NT Ext Equity Mkt Idx Fd - NL1.85K0.02%-
NT Ext Equity Mkt Idx Fd - DC - NL - T21.49K0.01%-74.00
Northern Trust Extended Eq Market Idx1.48K0.01%-
NT Ext Equity Mkt Idx Fd - L1.48K0.01%-
Fidelity Nasdaq Composite Index1.25K0.01%-
Spartan Total Market Index Pool E884.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 18, 2022Moss Ronald B. Chief Medical OfficerSell$4.95K
Mar 18, 2022Marguglio David J. SVP and Chief Business OfficerSell$7.12K
Mar 18, 2022CARLO DENNIS J PHD President & CEOSell$6.29K
Mar 18, 2022Benedicto David C. Chief Financial OfficerSell$2.21K
Dec 01, 2021Benedicto David C. Chief Financial OfficerSell$10.64K

Insider Transactions Trends

DateBuySell
2022 Q4--
2022 Q2--
2022 Q1-4
2021 Q4-4
2021 Q2--

ADMP Ownership FAQ

Who Owns Adamis Pharmaceuticals?

Adamis Pharmaceuticals shareholders are primarily institutional investors at 18.04%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Adamis Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 33.38%, which Adamis Pharmaceuticals falls below.

Does Blackrock own Adamis Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Adamis Pharmaceuticals.

Who is the top mutual fund holder of Adamis Pharmaceuticals shares?

Fidelity® Extended Market Index is the top mutual fund holder of Adamis Pharmaceuticals shares, with 1.96% of its total shares outstanding invested in 197.42K Adamis Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools